Cassava Sciences Inc.

SAVA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.32

+$0.03 (+2.33%)

At close: May 22, 2026, 12:35 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.33%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Sep 30, 2026

18.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $63.77M

1D Range

1.27 1.35

52W Range

1.15 4.98

Valuation (TTM)

PE -1.52

PB 1.00

EV/EBITDA 0.24

Valuation (NTM)

Forward PE N/A

Forward PEG 0.03

Price Target N/A

Cash Flow

FCF Yield -46.0%

SBC Adj. FCF Yield -74.0%

SBC Impact -61.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -18.0% | 5.0%

FCF 3Y | 5Y 40.4% | 11.6%

Returns

ROA -40.7%

ROE -58.8%

ROIC -70.9%

Financial Health

Net Cash

$82.68M

Current Ratio 2.08

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Cassava Sciences, Inc. is a biopharmaceutical enterprise in the clinical development phase, specializing in the creation of treatments for neurodegenerative disorders. The company's primary experiment...

Sector Healthcare

Industry Biotechnology

Employees 30

IPO Date Jul 14, 2000

Website www.filanatx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.